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Introduction {#sec1}
============

Inbred mice play a major role in biomedical research by allowing researchers to perform reproducible experiments in a uniform genetic background. The C57BL/6 mouse strain is currently one of the most commonly used inbred mouse strains. In 1948 the C57BL/6J mouse (J mice) strain was established at the Jackson Laboratory. In 1951 the National Institutes of Health established a J-mouse colony designated "C57BL/6N" (N mice). In 1974 the Charles Rivers Laboratory began to its own C57BL/6N colony, which was called "C57BL/6NCrl" (referred to here as N mice). J mice and N mice, which are now separated by approximately 200 generations, display phenotypic differences ([@bib4], [@bib12], [@bib30], [@bib32], [@bib35], [@bib39], [@bib41]) in glucose metabolism ([@bib9], [@bib17], [@bib44]), alcohol metabolism ([@bib11], [@bib22]), and drug (anesthetic, tumorigenic) sensitivity ([@bib5], [@bib37]). Whole-genome comparisons of N and J mice have revealed 34 coding SNPs, two coding insertion/deletions (indels), 146 non-coding SNPs, 54 non-coding indels, and 43 structural variants ([@bib40]). Importantly, J mice also possess a five-exon deletion in the *Nicotinamide nucleotide transhydrogenase* (*Nnt*) gene ([@bib17]). In mammalian cells, NNT is integral to the inner mitochondrial membrane where it catalyzes the reversible transfer of hydrogen between NAD^+^ and NADP^+^. Consequently, J mice display significantly impaired mitochondrial function ([@bib36]). NNT also regulates mitochondrial redox via the glutathione and thioredoxin/peroxiredoxin pathways ([@bib14]). J mice have differential sensitivity to genetic deletion of antioxidant proteins, which is believed to be a direct result of the loss of *Nnt* ([@bib17], [@bib18]). Knockout mice for genes like *Sod2* generated on a J background display tissue damage even under homeostatic conditions ([@bib17], [@bib18]). However, despite these known phenotypic and genotypic differences, about 58% of published studies using C57BL/6 mice do not fully describe their genetic background ([@bib8]).

C57BL/6 mice are heavily used in the study of hematopoietic stem cells (HSCs) and transplantation because of the convenience of the CD45 congenic system to track hematopoietic repopulating activity. HSCs can reconstitute the entire hematopoietic system after transplantation into hosts whose own hematopoietic compartment has been ablated. One of the most harmful phenomena occurring during HSC transplantation (HSCT) is the increase in both intracellular and extracellular reactive oxygen species (ROS) ([@bib28]). ROS are by-products of oxidative phosphorylation for energy production. Cellular antioxidants function continuously to control ROS levels, thereby regulating the proliferation, growth, signal transduction, and gene expression of the cells ([@bib2], [@bib3], [@bib6], [@bib25]). Nevertheless, when ROS levels increase dramatically or the antioxidant capacity of cells is compromised, ROS stress occurs. During transplantation, HSCs are sequentially exposed to dramatically different oxygen environments: hypoxia (in bone marrow \[BM\]), relatively low oxygen when recruited to the circulation during mobilization, normoxia (after collection or during *in vitro* culture), relatively low oxygen again after intravenous reinfusion, and finally hypoxia (after homing back to the BM) ([@bib13]). Elevated ROS levels are well known to compromise HSC lifespan ([@bib20]), self-renewal ([@bib19], [@bib24]), and differentiation ([@bib1], [@bib29]). However, despite the known sensitivities of HSCs and their downstream progenitors to ROS levels, it has never been reported whether hematopoietic stem and progenitor cells (HSPCs) isolated from J and N mice are functionally equivalent.

Thus, here we examined the frequency and function of HSPCs isolated from N and J mice. We discovered that N-HSPCs display superior short-term repopulating activity relative to J-HSPCs and that J-HSPCs are much more sensitive to oxidative stress. Also, *Nnt* knockdown in N-HSPCs recapitulates the functional defects seen in J-HSPCs. These findings highlight the necessity for intense scrutiny when determining the appropriate genetic background in studies involving HSPCs, especially those involving HSCT. Furthermore, our findings emphasize the importance of proper reporting of genetic background in peer-reviewed articles.

Results {#sec2}
=======

C57BL/6N and C57BL/6J Mice Display Similar Frequencies of Peripheral Blood and Bone Marrow Hematopoietic Populations {#sec2.1}
--------------------------------------------------------------------------------------------------------------------

We first examined whether there were any overt differences in the distribution of the mature blood lineages in N and J mice. No differences were seen in either absolute blood counts or the relative frequencies of peripheral blood (PB) B cells, T cells, or myeloid cells in 8- to 10-week-old N and J mice ([Figure S1](#mmc1){ref-type="supplementary-material"}A). We also examined N- and J-mouse BM for the absolute frequency of HSPCs. We saw no differences in the relative frequency of long-term HSCs (LT-HSC; Lin^−^SCA1^+^CKIT^+^FLT3^−^CD48^−^CD150^+^), short-term HSCs (ST-HSC; Lin^−^SCA1^+^CKIT^+^FLT3^−^CD48^−^CD150^−^), multi-potent progenitors (MPP2: Lin^−^SCA1^+^CKIT^+^FLT3^−^CD48^+^CD150^+^; MPP3: Lin-SCA1^+^CKIT^+^FLT3^−^CD48^+^CD150^−^; MPP4: Lin-SCA1^+^CKIT^+^FLT3^+^CD48^+^CD150^−^), common myeloid progenitors (CMP; Lin^−^SCA1^−^CKIT^+^CD34^+^CD16/32^med^), granulocyte-macrophage progenitors (GMP; Lin^−^SCA1^−^CKIT^+^CD34^+^CD16/32^high^), megakaryocyte-erythroid progenitors (MEP; Lin^−^SCA1^−^CKIT^+^CD34^−^CD16/32^−^), or common lymphoid progenitors (CLP; Lin^−^SCA1^med^CKIT^med^CD127^+^) in these mice ([Figure S1](#mmc1){ref-type="supplementary-material"}B). To grossly examine their function, we isolated BM Lineage^−^SCA-1^+^CKIT^+^ (LSK) cells from N and J mice and tested them for colony-forming unit (CFU) potential in semi-solid media supplemented with hematopoiesis-promoting cytokines. We observed no differences in the absolute number or types of CFUs yielded by N- and J-LSK cells ([Figure S1](#mmc1){ref-type="supplementary-material"}C).

J-HSPCs Display Compromised Short-Term *In Vivo* Repopulating Activity {#sec2.2}
----------------------------------------------------------------------

We next examined the *in vivo* repopulating potential of N- and J-HSPCs. Here, LSK cells isolated from 8- to 10-week-old N or J mice (CD45.2^+^) were transplanted along with an equal number of competitor LSK cells (CD45.1^+^) into lethally irradiated recipients (CD45.1/CD45.2^+^) ([Figure 1](#fig1){ref-type="fig"}A). For 12 weeks post transplant, N-HSPCs displayed significantly increased repopulation of recipient PB relative to J-HSPCs ([Figure 1](#fig1){ref-type="fig"}B). This advantage was transient, no longer significant at 16 and 20 weeks post transplant, and appeared primarily driven by enhanced reconstitution of the B and T cell lineages ([Figure 1](#fig1){ref-type="fig"}C). BM from primary recipients was next transplanted into secondary recipients ([Figure S2](#mmc1){ref-type="supplementary-material"}A). In secondary recipients, J-BM cells also displayed a short-term repopulating defect relative to N-BM cells ([Figure S2](#mmc1){ref-type="supplementary-material"}B). Examination of the major BM compartments (BMC) of primary recipients revealed significantly enhanced reconstitution of donor-derived CLPs of N recipients relative to J recipients at 4 and 8 weeks post transplant ([Figure 1](#fig1){ref-type="fig"}D). This enhanced chimerism was absent by 12 weeks post transplant ([Figure 1](#fig1){ref-type="fig"}D), which is consistent with the short-term repopulating advantage seen in the lymphoid PB lineages of these recipients.Figure 1J-HSPCs Display a Short-Term Repopulating Defect(A) N- or J-LSK cells (CD45.2) were mixed 1:1 with competitor LSK cells (CD45.1) and injected into lethally irradiated recipient mice (CD45.1/CD45.2). CD45.2^+^ chimerism of the PB was examined by flow cytometry every 4 weeks for 20 weeks post transplant.(B) Normalized CD45.2^+^ chimerism in total recipient PB after transplant.(C) Normalized CD45.2^+^ chimerism among the myeloid (GR1^+^CD11B^+^) and lymphoid (B cells as B220^+^ and T cells as CD4^+^CD8^+^) lineages in the recipient PB post transplant.(D) Normalized CD45.2^+^ chimerism among the BMC at 4, 8, and 12 weeks post transplant. Data presented are normalized to the CD45.2^+^ chimerism observed in recipients of J-LSK cells.Data from three independent transplants are presented as mean ± SEM. Donor mice, n ≥ 3 pooled per transplant. Recipient mice, n ≥ 5 per transplant. ^∗^p \< 0.05, ^∗∗^p \< 0.005, ^∗∗∗^p \< 0.001, significantly different from recipients of J-LSK cells.

We next quantified the frequency of long-term competitive repopulating units (CRUs) in J and N mice via limiting dilution transplant. J- or N-BM (CD45.2^+^) was transplanted at limiting dilution along with a 200,000 competitive BM cells (CD45.1^+^) into lethally irradiated recipient mice (CD45.1/CD45.2^+^) ([Figure 2](#fig2){ref-type="fig"}A). Again, J-BM displayed a transient repopulating defect relative to N-BM ([Figure 2](#fig2){ref-type="fig"}B). We next applied Poisson statistics to calculate the number of repopulating units in each substrain. There was no significant difference in the frequency of CRUs in J- and N-BM ([Figure 2](#fig2){ref-type="fig"}C), confirming that the repopulating defect in the J-HSPCs is restricted to short-term progenitors.Figure 2J and N Mice Have Similar Numbers of Long-Term Functional Repopulating Units(A) Decreasing numbers of N- or J-BM cells (CD45.2) were mixed with 200,000 competitor BM cells (CD45.1) and injected into lethally irradiated recipient mice (CD45.1/CD45.2). CD45.2^+^ chimerism of the PB was examined by flow cytometry every 4 weeks for 16 weeks post transplant.(B) CD45.2^+^ chimerism in total recipient PB after transplant.(C) At 16 weeks post transplant, recipients were scored as non-engrafted or engrafted (i.e., CD45.2^+^ PB chimerism \>1% in the T cell, B cell, and myeloid cell lineages) and the frequency of HSC (i.e., CRUs) calculated via Poisson statistics. χ^2^ analysis revealed a good fit to the limiting dilution model.Data are presented as mean ± SEM. Donor mice, n ≥ 3 pooled per transplant. Recipient mice, n ≥ 7 per transplant.^∗^p \< 0.05, ^∗∗^p \< 0.005, ^∗∗∗^p \< 0.001, significantly different from recipients of J-BM cells.

J-HSPC Short-Term Repopulating Defect Results from Perturbed Function of MPP3 and MPP4 Cells Post Transplant {#sec2.3}
------------------------------------------------------------------------------------------------------------

LSK cells comprise multiple HSPC populations that display distinct repopulation kinetics and lineage potential post transplant ([@bib34], [@bib47]) ([Figure 3](#fig3){ref-type="fig"}A). Thus, to better define the short-term repopulating defect of J-LSK cells, we next examined the repopulating activity of LT-HSC, ST-HSC, MPP2, MPP3, and MPP4 cells isolated from N and J mice. Each population was isolated from N- and J-mouse BM (CD45.2) and transplanted into sublethally irradiated recipients (CD45.1/CD45.2^+^) ([Figure 3](#fig3){ref-type="fig"}B). J- and N-HSPC subpopulations displayed similar lineage output post -transplant ([Figure 4](#fig4){ref-type="fig"}). However, N-MPP3 and N-MPP4 cells displayed superior repopulating activity relative to J-MPP3 and J-MPP4 cells as early as 10--15 days post transplant ([Figure 3](#fig3){ref-type="fig"}C). An examination of the BM of transplant recipients revealed that N-MPP3 and N-MPP4 cells repopulated the CLP compartment more robustly than J-MPP3 and J-MPP4 cells 1 month post transplant ([Figure S3](#mmc1){ref-type="supplementary-material"}). MPP3 and MPP4 cells reconstitute lymphoid populations in the PB before other HSPC compartments ([Figure 4](#fig4){ref-type="fig"}) ([@bib34]). The failure to robustly repopulate the CLP compartment at early time points post transplant likely contributes to the short-term PB repopulating defect of J-HSPCs relative to N-HSPCs. Furthermore, the overall output of J-MPP3 and J-MPP4 cells is similar post transplant, while N-MPP3 cells contribute more robustly to both the PB and BMC than N-MPP4 cells ([Figures 3](#fig3){ref-type="fig"}C and [S3](#mmc1){ref-type="supplementary-material"}). Thus, the relative behavior of these HSPC subsets is different after transplant between these strains of mice.Figure 3J-MMP3 and J-MPP4 Display a Repopulating Defect Relative to N-MPP3 and N-MPP4(A) Schematic representation of the multipotent progenitor hierarchy and their relative contribution to the PB lineages (adapted from [@bib34]).(B) CD45.2 N or J-HSPCs (LT-HSC, ST-HSC, MPP2, MPP3, and MPP4) were transplanted into sublethally irradiated recipients (CD45.1/CD45.2). Recipient PB was examined for CD45.2^+^ cells and myeloid (GR1^+^CD11B^+^) and lymphoid (B cells as B220^+^ and T cells as CD4^+^CD8^+^) cells by flow cytometry every 3--4 days for 33--100 days.(C) Chimerism percentage in the recipient mice PB after transplant.Data from two independent transplants are presented as mean ± SEM. Donor mice, n = 3 pooled per transplant. Recipient mice, n = 5 per transplant. ^∗^p \< 0.05, ^∗∗^p \< 0.005, ^∗∗∗^p \< 0.001, significantly different from recipients of J-HSPCs.Figure 4J- and N-HSPC Subpopulations Display Similar Lineage Output Post TransplantHSPC subpopulations (LT-HSC, ST-HSC, MPP2, MPP3, and MPP4) from J or N mice (CD45.2) were transplanted into sublethally irradiated recipients (CD45.1/CD45.2). Recipient PB was examined for CD45.2^+^ cells and myeloid (GR1^+^CD11b^+^) and lymphoid (B cells as B220^+^ and T cells as CD4^+^CD8^+^) cells by flow cytometry every 3--4 days for 33--100 days. Percentage of myeloid, B, and T cells among the CD45.2^+^ cells produced by HSPC subpopulations post transplant. Data from two independent transplants are presented as mean ± SEM. Donor mice, n = 3 pooled per transplant. Recipient mice, n = 5 per transplant. ^∗^p \< 0.05, significantly different to recipients of J-HSPCs.

J-HSPCs Display Higher Levels of Oxidative Stress than N-HSPCs Post Transplant and in Response to pI:pC Injection {#sec2.4}
-----------------------------------------------------------------------------------------------------------------

As the *Nnt* gene is non-functional in C57BL/6J mice, and NNT is well known to regulate oxidative stress ([@bib14]), we next examined ROS levels in the BM of mice transplanted with N- or J-LSK cells. For these experiments, J- and N-LSK cells were transplanted competitively as depicted in [Figure 1](#fig1){ref-type="fig"}A and recipient CD45.2^+^ BMCs analyzed at 4, 8, 12, and 20 weeks post transplant for ROS levels using the ROS reporter CellROX Deep Red ([@bib26], [@bib42]). ROS levels were significantly higher in the donor-derived CLP compartment of mice transplanted with J-LSK cells relative to N-LSK cell recipients up to 12 weeks post transplant ([Figure 5](#fig5){ref-type="fig"}). J-derived ST-HSC also displayed elevated ROS at 4 and 8 weeks post transplant ([Figure 5](#fig5){ref-type="fig"}). These data suggest that N-ST-HSCs and CLPs cope with transplant-induced oxidative stress better than J-ST-HSCs and CLPs, and are consistent with a short-term repopulating defect driven primarily by a loss of lymphoid repopulation.Figure 5BMC Derived from Transplanted J-HSPCs Display Elevated ROS Levels Post TransplantN- or J-LSK cells (CD45.2) were mixed 1:1 with competitor LSK cells (CD45.1) and injected into lethally irradiated recipients (CD45.1/CD45.2). Normalized CellROX fluorescence in CD45.2^+^ cells in each BMC after 4 (A), 8 (B), 12 (C), and 20 (D) weeks after transplant. Data presented are normalized to the fluorescence levels in J mice. Data from two independent transplants are presented as mean ± SEM. Donor mice, n ≥ 3 pooled per transplant. Recipient mice, n ≥ 4 per time point. ^∗^p \< 0.05, ^∗∗^p \< 0.005, significantly different from recipients of J-LSK cells.

To further explore the sensitivity of J- and N-HSPCs to oxidative stress, we next examined the response of J- and N-BM HSPCs to ROS induction via treatment with polyinosinic:polycytidylic acid (pI:pC). pI:pC mimics viral infection by inducing a type I interferon response, which causes an increase of ROS in HSCs ([@bib45]). The BMC of N and J mice injected with pI:pC were examined 24 hr post injection ([Figure 6](#fig6){ref-type="fig"}A). N and J mice both responded to pI:pC injection by increasing BMC numbers and ROS levels in all BMC examined relative to controls ([Figures 6](#fig6){ref-type="fig"}B and [S4](#mmc1){ref-type="supplementary-material"}). However, the magnitude of ROS increase was significantly greater in J mice than in N mice in all compartments examined except committed myeloid progenitors (i.e., CMP, GMP, and MEP) ([Figure 6](#fig6){ref-type="fig"}B).Figure 6J-HSPCs Are Hypersensitive to Oxidative Stress Induction Relative to N-HSPCs(A) Experimental schematic. BMC ROS levels and CFU potential were examined in J and N mice 24 hr after treatment with pI:pC.(B) CellROX Deep Red fluorescence was measured in BMC from N and J control mice and after pI:pC injection. Fluorescence was normalized to the values of J control cells, and the increase of fluorescence between control and pI:pC injected mice was calculated.(C--E) Number (C), size (D), and distribution (E) of CFUs generated by HSPCs from N and J control mice and after pI:pC injection.(F and G) Number (F) and size (G) of pre-B colonies generated by HSPCs from N and J control mice and after pI:pC injection. ZnCl~2~ was added to CFU and pre-B colonies assays to increase the production of ROS.Data are presented as mean ± SEM, n ≥ 3. ^∗^p \< 0.05, ^∗∗^p \< 0.005.

HSPCs from N and J mice treated and not treated with pI:pC were also assayed for CFU potential. We observed a significant decrease in both the number and size of CFUs produced by J-HSPC pI:pC-treated mice ([Figures 6](#fig6){ref-type="fig"}C and 6D). J-HSPCs isolated from pI:pC-treated mice also yielded fewer mixed-lineage colonies (e.g., CFU-GEMM and CFU-GM) ([Figure 6](#fig6){ref-type="fig"}E). Similarly, BM from N and J mice treated or untreated with pI:pC was tested for pre-B-CFU potential ([Figures 6](#fig6){ref-type="fig"}F and 6G). Although we did not detect any differences in absolute numbers of pre-B-CFUs from N and J cells, we did observe a mild decrease in the size of the colonies generated by J-HSPCs after pI:pC treatment, relative to N-HSPCs ([Figures 6](#fig6){ref-type="fig"}F and 6G). These changes were all exacerbated by the addition of ZnCl~2~, which further increases oxidative stress ([@bib23], [@bib46]). In sum, J-HSPCs display increased sensitivity to induced oxidative stress relative to N-HSPCs, which disparately affects their self-renewal and differentiation potential, as reflected by CFU numbers, type, and colony size.

*Nnt* Loss Contributes to the Repopulating Defect of J-HSPCs {#sec2.5}
------------------------------------------------------------

One major genetic difference between J and N mice is the disruption of the *Nnt* gene ([@bib17]). In N-HSPCs, *Nnt* expression is largely restricted to MPP subsets rather than HSCs, consistent with our previous observations ([Figure S5](#mmc1){ref-type="supplementary-material"}A). To determine whether loss of *Nnt* contributes to the J-HSPC phenotype, we next tested whether *Nnt* knockdown in N-HSPCs recapitulates the PB repopulating defect of J-HSPCs. To this end, J- and N-LSK cells isolated from 8- to 10-week-old mice (CD45.2^+^) were transduced with lentiviral control or *Nnt* short hairpin RNAs (*Nnt-*shRNAs). Transduced cells (i.e., mCherry^+^) were then sorted and transplanted along with an equal number of competitor mock-transduced LSK cells (CD45.1^+^) into lethally irradiated recipients (CD45.1/CD45.2^+^) ([Figures 7](#fig7){ref-type="fig"}A and 7B). Knockdown of *Nnt* in N-HSPCs yielded a short-term PB repopulating defect that mirrored that of J-HSPCs ([Figure 7](#fig7){ref-type="fig"}C). As expected, treatment of J-HSPCs with *Nnt*-shRNAs had no effect on their repopulating activity, confirming the specificity of *Nnt-*shRNAs ([Figure 7](#fig7){ref-type="fig"}D). *Nnt* knockdown in N-HSPCs also recapitulated the short-term CLP repopulating defect ([Figure S5](#mmc1){ref-type="supplementary-material"}B) and the increased ROS levels ([Figure S5](#mmc1){ref-type="supplementary-material"}C) of J-HSPCs. Thus, the absence of a functional *Nnt* gene in J-HSPCs very likely contributes directly to their short-term repopulating defect and hypersensitivity to stress-induced ROS.Figure 7*Nnt* Knockdown in N-HSPCs Recapitulates J-HSPC Short-Term Repopulating Defect(A) miR30-embedded shRNAs targeting *Nnt* were cloned into a lentiviral vector downstream of the MSCV promoter. The phosphoglycerate kinase (PGK) promoter drives mCherry.(B) LSK cells isolated from N or J mice (CD45.2^+^) were transduced with lentivirus containing control or *Nnt*-shRNAs. Transduced cells (i.e., mCherry^+^) were then isolated and transplanted with an equal number of competitor LSK cells (CD45.1^+^) into lethally irradiated recipients (CD45.1/CD45.2^+^). Recipient PB was monitored by flow cytometry every 4 weeks for 20 weeks post transplant for CD45.2^+^ mCherry^+^ cells.(C) Normalized percentage of CD45.2^+^ mCherry^+^ cells in the recipient mice PB after transplant. Data normalized to the CD45.2^+^ mCherry^+^ chimerism observed in recipients of J-LSK cells transduced with control shRNA.(D) *Nnt* normalized gene expression in N-LSK cells transduced with control or *Nnt*-shRNAs.Data from two independent transplants are presented as mean ± SEM. Donor mice, n = 3 per transplant. Recipient mice, n = 5 per transplant. ^∗^p \< 0.05, ^∗∗^p \< 0.005, ^∗∗∗^p \< 0.001, significantly different from recipients of J-LSK cells transduced with control shRNA.

Discussion {#sec3}
==========

Here, we compared the hematopoietic system of two commonly used C57BL/6 mice substrains (J and N). One major genetic difference between these substrains is the disruption of the *Nnt* gene in J mice ([@bib17]), which encodes one of the main enzymes controlling oxidative stress ([@bib14]). HSPCs experience severe oxidative stress during HSCT ([@bib28]). Our results reveal that J-HSPCs have a significant disadvantage in short-term PB repopulating activity after transplant relative to N-HSPCs. This disadvantage is most acute in the lymphoid lineages (B and T cells) and coincides with a reduced ability to reconstitute the CLP compartment post transplant. We further determined that this repopulating defect results specifically from the compromised function of J-MPP3 and J-MPP4 cells post transplant. MPP3 and MPP4 cells are responsible for the short-term reconstitution of lymphoid lineages at acute time points post transplant. Indeed, J-HSPCs, particularly J-CLPs, displayed higher levels of ROS both post transplant and in response to oxidative stress. Finally, we show that knockdown of *Nnt* in N-HSPCs recapitulates the repopulating defect of J-HSPCs after transplantation, strongly suggesting that *Nnt* loss is a major contributor to the functional differences of J- and N-HSPCs during HSCT.

The absolute output of discrete HSPC compartments relative to each other post transplant has been described ([@bib34]). In our comparison of C57BL/6J and C57BL/6N substrains, we noted differences in the absolute output of distinct HSPC compartments between J and N mice. Specifically, while J-MPP3 and J-MPP4 cells were similar in their absolute contribution to the PB post transplant, N-MPP3 cells contributed significantly more cells to the PB than N-MPP4 cells after transplantation. Furthermore, both N-MPP3 and N-MPP4 cells contributed more to PB and BM populations than J-MPP3 and J-MPP4 cells. Thus, the behavior of MPP3 and MPP4 cells relative to each other post transplant differs between C57BL/6 substrains. These differences could skew results and conclusions depending on which substrain is utilized for a particular set of experiments.

Murine HSPCs with low ROS levels are more quiescent and exhibit an increased self-renewal potential compared with HSPCs with higher ROS levels ([@bib43]). Our results reveal that some J-HSPC-derived BMC contain higher ROS levels acutely post transplant than BMC reconstituted by N-HSPCs. This finding suggests that J-HSPCs manage oxidative stress levels poorly relative to N-HSPCs during transplantation. This elevated ROS likely contributes to the short-term repopulating defect of J-HSPCs. Furthermore, ROS induction via treatment with pI:pC injections revealed that J-HSPCs fail to resolve elevated oxidative stress as efficiently as N-HSPCs, which was detrimental to their self-renewal and differentiation potential. It is also important to emphasize that unlike the functional differences apparent after transplant, no difference in the frequency of any BMC or PB lineage between these two substrains was observed at steady state. This reinforces the idea of stress during transplantation as the cause of the repopulating defect in J-HSPCs.

We propose that the lack of the *Nnt* gene in J-HSPCs specifically diminished their *in vivo* repopulating activity due to a compromised ability to respond to elevated oxidative stress during transplantation relative to N-HSPCs. This deficiency was most apparent in lymphoid cells and their upstream progenitors. Although higher *Nnt* expression levels in MPPs compared with HSCs could explain the heightened sensitivity of MPP3s and MPP4s to *Nnt* loss, further studies are needed to clarify this point. LT-HSCs are the most multi-potent and have the highest self-renewal potential among the HSPC subsets ([@bib34]). In addition, LT-HSCs contribute to maintaining the hematopoietic system throughout life ([@bib33], [@bib38]). Altogether this makes them key players in the hematopoietic hierarchy. Thus, it is possible that LT-HSCs have developed redundant mechanisms to manage excessive ROS during hematopoietic stress, which could otherwise compromise their survival. On the other hand, MPP3 and MPP4 turn over more rapidly and are more restricted in their lineage potential. For this reason, they may not have developed the same repertoire of redundant mechanisms. Interestingly, the lymphoid potential of these progenitors appears to be most sensitive to compromised regulation of ROS levels. Emerging evidence reveals that the differentiation state of lymphocytes largely determines their fate in terms of function and persistence. Although several studies describe the functional consequences of oxygen radical-related immune-regulation, relatively little is known about the sensitivity of individual lymphocyte subsets and progenitors to oxidative stress ([@bib21]). For example, ROS are thought to have effects on T cell function and proliferation ([@bib21]). Low concentrations of ROS in T cells are a prerequisite for cell survival, while increased ROS accumulation can lead to apoptosis/necrosis ([@bib21]). In Ts65Dn mice, a model for Down syndrome, there is a decrease in CLPs due to higher levels of oxidative stress associated with a reduction of interleukin-7R ([@bib27]), which plays an essential role in lymphoid development and homeostasis by promoting proliferation and inhibiting apoptosis ([@bib10], [@bib31]).

Many studies that use C57BL/6 mice fail to specify their precise genetic background ([@bib8]). Only 36 of 197 papers with the term "hematopoietic progenitors" in the title and the term "C57BL" in any other field indicated the specific C57BL/6 substrain employed in their study. This is concerning given that multiple vendors distribute genetic mouse models in different C57BL/6 substrains. Indeed, there are C57BL/6J substrains that do not have the mutation in *Nnt* found in other J substrains and therefore are not suitable controls for the C57BL/6J animals distributed by the Jackson Laboratory ([@bib8]). The International Knockout Mouse Consortium generates targeted embryonic stem cells and knockout mice in the N substrain, while many Cre-recombinase lines are in J mice ([@bib8]). Therefore, careful attention to background substrain and/or backcrossing is necessary to avoid these confounding variables ([@bib8]). Given our evidence that C57BL/6J and C57BL/6N HSPCs are not functionally equivalent, investigators should be cautious and be aware of the genetic background of any mouse model used in studies focused on oxidative stress and mitochondrial function in hematopoiesis; as well as those studies involving short-term reconstitution of the hematopoietic system and the contribution of specific HSPC populations to this process.

Experimental Procedures {#sec4}
=======================

Mice {#sec4.1}
----

C57BL/6J mice and competitor mice (B6.SJL) were purchased from the Jackson Laboratory (Bar Harbor, ME), C57BL/6NCrl mice were obtained from the Charles Rivers Laboratory (Wilmington, MA). Recipient mice (CD45.1/CD45.2) were obtained by crossing C57BL/6J CD45.1 and C57BL/6J CD45.2 from the Jackson Laboratory. Mice were housed in our facilities for at least 3 weeks before each experiment. For all experiments, mice were 6--10 weeks old. All animal experiments were carried out according to procedures approved by the St. Jude Children\'s Research Hospital Institutional Animal Care and Use Committee, and all animals were housed in a pathogen-free facility.

Flow-Cytometry Analysis of Peripheral Blood and Bone Marrow {#sec4.2}
-----------------------------------------------------------

PB was collected from the retro-orbital sinus as previously described ([@bib15]). PB chimerism and lineages post transplant were analyzed using an LSR Fortessa (BD Biosciences, San Jose, CA) after staining with anti-GR1 PerCP Cy5.5 (RB6-8C5) (eBiosciences \#15-5931-83), anti-B220 PerCP Cy5.5 (RA3-6B2) (Biolegend \#103235), anti-CD11B PerCP Cy5.5 (M1/70) (Biolegend \#101228), anti-B220 PE Cy7 (RA3-6B2) (Tonbo Biosciences \#60-0452-U100), anti-CD4 PE Cy7 (RM4-5) (Tonbo Biosciences \#60-0042-U025), anti-CD8 PE Cy7 (53-6.7) (Tonbo Biosciences \#60-0081-U100), anti-CD45.1 FITC (104) (Biolegend \#110706), and anti-CD45.2 V500 (A20) (BD \#562129) (all at 1:200 dilution). DAPI (Sigma-Aldrich, St. Louis, MO) was used for dead cell exclusion.

BM was extracted from mice tibias, femurs, and pelvic bones. Bones were crushed and incubated in red blood cell lysis buffer (Sigma-Aldrich) for 5 min on ice. BMCs were visualized by flow cytometry after staining with the following antibodies: HSC-LT/HSC-ST/MPP2/MPP3/MPP4 (B220-PerCP \[RA3-6B2\] \[Biolegend \#553093\], CD3-PerCP \[145-2C11\] \[Biolegend \#100326\], CD4-PerCP \[GK1.5\] \[Biolegend \#100432\], CD8-PerCP \[53-6.7\] \[Biolegend \#100732\], CD19-PerCP \[6D5\] \[Biolegend \#115532\], GR1-PerCP \[RB6-8C5\] \[Biolegend \#108426\], TER119-PerCP \[TER-119\] \[Biolegend \#116226\], SCA1-PerCP-Cy5.5 \[E13-161.7\] \[Biolegend \#122524\], CKIT-APC-780 \[2B8\] \[eBiosciences \#47-1171-82\], CD150-PE-Cy7 \[TC15-12F12.2\] \[Biolegend \#115914\], CD48-Alexa Fluor 700 \[HM48-1\] \[Biolegend \#103426\], FLT3-PE \[A2F10.1\] \[BD \#553842\], CD45.1-FITC \[104\] \[Biolegend \#110706\], and CD45.2-v500 \[A20\] \[BD \#562129\]); CMP/GMP/MEP (B220-PerCP \[RA3-6B2\], CD3-PerCP \[145-2C11\], CD4-PerCP \[GK1.5\], CD8-PerCP \[53-6.7\], CD19-PerCP \[6D5\], GR1-PerCP \[RB6-8C5\], TER119-PerCP \[TER-119\], SCA1-PerCP-Cy5.5 \[E13-161.7\], CKIT-APC-780 \[2B8\], FCR II/III-Alexa Fluor 700 \[93\] \[Biolegend \#101317\], CD34-FITC \[RAM34\] \[BD \#553733\], CD45.1-FITC \[104\], and CD45.2-v500 \[A20\]); and CLP (B220-PerCP \[RA3-6B2\], CD3-PerCP \[145-2C11\], CD4-PerCP \[GK1.5\], CD8-PerCP \[53-6.7\], CD19-PerCP \[6D5\], GR1-PerCP \[RB6-8C5\], TER119-PerCP \[TER-119\], SCA1-PerCP-Cy5.5 \[E13-161.7\], CKIT-APC-780 \[2B8\], IL-7R-PE-Cy7 \[A7R34\] \[Tonbo Biosciences \#60-1271-U100\], CD45.1-FITC \[104\], and CD45.2-v500 \[A20\]) (all at 1:200; except CD34 at 1:50). Populations were identified according to the gating strategy described in [Figure S6](#mmc1){ref-type="supplementary-material"}. DAPI (Sigma-Aldrich) was used for dead cell exclusion.

For PB and BM, data analysis was performed with FlowJo version 10 (LLC, Ashland, OR).

LSK (Lineage-SCA1^+^CKIT^+^) Cell Preparation {#sec4.3}
---------------------------------------------

BM was extracted from femur, pelvic bone, and tibias via crushing. CKIT^+^ cells were isolated via magnetic enrichment using anti-CD117 microbeads (Miltenyi Biotec, Carlsbad, CA) and an autoMACs magnetic cell separator (Miltenyi Biotec). Cells were then stained with anti-SCA1 PerCPCy5.5 (E13-161.7) and anti-CKIT APCe780 (2B8) to facilitate isolation of LSK cells by cell sorting on FACSAria III (BD Biosciences).

LSK Cell Transplantation {#sec4.4}
------------------------

LSK cells from N and J mice were transplanted into CD45.1/CD45.2 recipient mice pre-irradiated with 11 Gy (two doses of 5.5 Gy separated by 3 hr). A 150-μL solution of PBS containing 5,000 test (J or N) LSK cells (CD45.2) and 5,000 competitor LSK cells (CD45.1) was injected into each recipient mouse via tail vein. Recipient mice received antibiotics (enrofloxacin, 1 mL/9.1 kg) in their water for 10 days post transplant. The frequency of CD45.2- and CD45.1-positive PB cells was assessed by flow cytometry every 4 weeks post transplant for at least 20 weeks. To minimize biological variation, for each transplant we collected and pooled femur, tibia, and hip bones from three individuals for collection of BM via crushing.

Secondary Transplantation {#sec4.5}
-------------------------

BM cells from N- and J-LSK cells primary recipient mice were transplanted into CD45.1/CD45.2 recipient mice pre-irradiated with 11 Gy (two doses of 5.5 Gy separated by 3 hr). A 150-μL solution of PBS containing 10^6^ test (J or N) BM cells (CD45.2) was injected into each recipient mouse via tail vein. Recipient mice received antibiotics (enrofloxacin, 1 mL/9.1 kg) in their water for 10 days post transplant. The frequency of CD45.2- and CD45.1-positive PB cells was assessed by flow cytometry every 4 weeks post transplant for at least 20 weeks. To minimize biological variation, for each transplant we collected and pooled femur, tibia, and hip bones from five individuals for collection of BM via crushing.

### Limiting Dilution Transplants {#sec4.5.1}

J- or N-BM cells (15,000, 30,000, 50,000 or 100,000 CD45.2^+^) were injected with 2 × 10^5^ CD45.1^+^ WBM cells into lethally irradiated CD45.1^+^/CD45.2^+^ recipients. Engraftment was defined as \>1% CD45.2 chimerism in the T cell, B cell, and myeloid lineages of recipient PB after transplant. l-Calc (STEMCELL Technologies, Vancouver, Canada) was used to analyze the results of the limiting dilution transplants.

HSPC Subsets Transplantation {#sec4.6}
----------------------------

HSPC subsets (LT-HSC, ST-HSC, MPP2, MPP3, and MPP4) from N and J mice were transplanted into CD45.1/CD45.2 recipient mice sublethally pre-irradiated with 9.5 Gy (two doses of 4.75 Gy separated by 3 hr). A 150-μL solution of PBS containing 2,000 cells of each subset (CD45.2) was injected into each recipient mouse via tail vein. Recipient mice received antibiotics (enrofloxacin, 1 mL/9.1 kg) in their water for 10 days post transplant. The frequency of CD45.2 PB cells was assessed by flow cytometry every 3--4 days post transplant for 34--100 days.

Colony-Forming Unit Assays {#sec4.7}
--------------------------

Five hundred LSK cells were plated in M3434 methylcellulose (STEMCELL). Colonies were scored 8--10 days later. For pre-B CFU assays, 1 × 10^5^ BM cells were plated in M3630 methylcellulose (STEMCELL). Colonies were then scored 7 days later.

Oxidative Stress Induction Experiments {#sec4.9}
--------------------------------------

To provoke increased ROS in HSPCs, we injected 5 mg/kg of pI:pC intraperitoneally into J and N mice. Control J and N mice were injected with the same volume of PBS. Twenty-four hours later, BM was isolated from control and treated mice, and the BMC frequency and their ROS levels were analyzed by CellROX Deep Red (Thermo Fisher Scientific, Waltham, MA) staining and flow cytometry. Five hundred LSK cells were plated in M3434 methylcellulose (STEMCELL). Colonies were scored 8--10 days later. For pre-B CFU assays, 1 × 10^5^ BM cells were plated in M3630 methylcellulose (STEMCELL). Different concentrations of ZnCl~2~ were added to the methylcellulose to induce a further increase in ROS levels. Colonies were then scored 7 days later.

shRNAs {#sec4.10}
------

shRNAs were designed as previously described ([@bib7], [@bib16]). Gene knockdown (KD) efficiency in LSK cells was quantified by qRT-PCR after normalizing to transduction frequency ([Figure 7](#fig7){ref-type="fig"}D).

### *Nnt* shRNA1 {#sec4.10.1}

TGC TGT TGA CAG TGA GCG GGA GGA TAC GCG AAA GAG ATG TTA GTG AAG CCA CAG ATG TAA CAT CTC TTT CGC GTA TCC TCC TGC CTA CTG CCT CGG A.

### *Nnt* shRNA2 {#sec4.10.2}

TGC TGT TGA CAG TGA GCG GCT ATA ACA TCG AAG AAA TCA TTA GTG AAG CCA CAG ATG TAA TGA TTT CTT CGA TGT TAT AGC TGC CTA CTG CCT CGG A.

Lentiviral Production {#sec4.11}
---------------------

Vesicular stomatitis virus glycoprotein-pseudotyped lentivirus was prepared as previously described using a four-plasmid system (Transfer vector, Gag/Pol, Rev/Tat, and vesicular stomatitis virus glycoprotein envelope plasmid) by co-transfection of 293T cells using TransIT 293 (Mirus) ([@bib16]). Viral supernatant was collected 48 hr later, cleared, and stored at −80°C. Viral preparations were titered on 293T cells.

LSK Cell Culture and Transduction {#sec4.12}
---------------------------------

LSK cells were isolated from 6- to 10-week-old murine BM and transduced with lentivirus as previously described ([@bib16]). In brief, non-tissue culture 96-well plates were coated with Retronectin (TaKaRa Bio, Shiga, Japan) according to the manufacturer\'s instructions. Lentiviral particles corresponding to an MOI of 25 were spin loaded onto the plates for 1 hr at 1,000 × *g* at room temperature. Wells were washed with PBS, followed by the addition of 15,000 freshly isolated LSK cells resuspended in 200 μL of serum-free expansion medium (STEMCELL) with 10 ng/mL recombinant murine (RM) stem cell factor, 20 ng/mL RM thrombopoietin, 20 ng/mL RM insulin-like growth factor 2 (PeproTech, Rocky Hill, NJ), 10 ng/mL recombinant human fibroblast growth factor 1 (R&D Systems, Minneapolis, MN), and 5 μg/mL protamine sulfate (Sigma-Aldrich). Cells were incubated at 37°C. For collection of cells for transplantation 48 hr after transduction, medium was slowly removed and cells were washed and resuspended in PBS 1.5% fetal calf serum.

### *Nnt* Expression Quantification {#sec4.12.1}

HSPCs subsets (LT-HSC, ST-HSC, MPP2, MPP3, and MPP4) were isolated from N mice and *Nnt* expression was analyzed by qRT-PCR with the following primers:

Fw *Nnt*: TCC AAA ACG AGA AGC GAG TT.

Rv *Nnt*: TCC TTC ATC CCT TGG ATC TG.

Statistical Analysis {#sec4.13}
--------------------

Statistical significance for comparisons between two groups was assessed using two-sample t tests or exact Wilcoxon Mann-Whitney tests, depending on the normality test based on the Shapiro-Wilk test. Tests were performed using GraphPad Prism 4.0 software (GraphPad, San Diego, CA).
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